SHANGHAI BIORIGIN GENE DEV CO has a total of 17 patent applications. Its first patent ever was published in 1999. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are INST VIRAL DISEASE CONTROL & PREVENTION CHINESE CT DISEASE CONTROL & PREVENTION, CREATOGEN AG and RPMS TECHNOLOGY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 11 | |
#2 | China | 4 | |
#3 | Australia | 1 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Climate change adaptation technologies | |
#5 | Therapeutic chemical compounds | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Mao Yumin | 17 |
#2 | Xie Yi | 17 |
#3 | Huang Yan | 1 |
Publication | Filing date | Title |
---|---|---|
WO0119999A1 | A GENE ENCODING A NOVEL THREONYL-tRNA SYNTHETASE, ITS USES AND THE PREPARING METHODS | |
CN1373772A | Gene encoding human huntingtin interacting polypeptide which comprises WW domain and its producing method and application | |
CN1375007A | A gene encoding a novel threonyl-tRNA synthetase, its uses and the preparing methods | |
WO0123423A1 | A novel gene encodes the human huntingtin interacting polypeptide which comprises the ww domain and its producing method and application | |
CN1373773A | Polynucleotides encoding human angiotensin-II-1 receptor proteins and method of preparation and its use | |
CN1387535A | Novel muskelin and its application and producing method |